Testing effectiveness (Phase 2)Study completedNCT03866967What this trial is testingAnti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Akeso 130
Testing effectiveness (Phase 2)Looking for participantsNCT06242067What this trial is testingSecond-line Treatment of Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Qilu Hospital of Shandong University 50
Large-scale testing (Phase 3)Ended earlyNCT01006252What this trial is testingTasisulam-sodium Versus Paclitaxel as Treatment for Metastatic MelanomaWho this might be right forMelanoma Eli Lilly and Company 336
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07022301What this trial is testingSintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 TherapyWho this might be right forSmall Cell Lung Cancer Extensive StageResistance to Immunotherapy First Affiliated Hospital of Wannan Medical College 25
Testing effectiveness (Phase 2)UnknownNCT05447715What this trial is testingFruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Weijian Guo 134
Large-scale testing (Phase 3)Study completedNCT01767155What this trial is testingZoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial CancerWho this might be right forEndometrial Cancer AEterna Zentaris 511
Testing effectiveness (Phase 2)WithdrawnNCT03818997What this trial is testingCombination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric CancerWho this might be right forEsophageal CancerBiliary Tract CancerGastroEsophageal Cancer+1 more European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Active Not RecruitingNCT04833114What this trial is testingPolatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL)Who this might be right forRelapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma GWT-TUD GmbH 306
Large-scale testing (Phase 3)UnknownNCT01630733What this trial is testingA Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Achieve Life Sciences 700
Large-scale testing (Phase 3)Study completedNCT00478049What this trial is testingIressa as Second Line Therapy in Advanced NSCLC-AsiaWho this might be right forNSCLC AstraZeneca 163
Not applicableLooking for participantsNCT06751953What this trial is testingNeoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line TreatmentWho this might be right forColorectal Cancer (CRC) The First Affiliated Hospital of Nanchang University 10
Large-scale testing (Phase 3)Looking for participantsNCT06497985What this trial is testingTucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer PatientsWho this might be right forColorectal Cancer Chipscreen Biosciences, Ltd. 430
Post-approval studies (Phase 4)UnknownNCT04810585What this trial is testingPlasma Biomarker for Aflibercept in Advanced Colorectal CancerWho this might be right forRecurrent or Metastatic Colorectal Cancer Yonsei University 153
Testing effectiveness (Phase 2)Study completedNCT02945852What this trial is testingApatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.Who this might be right forSmall Cell Lung Cancer Fan Yun, MD 40
Early research (Phase 1)Not Yet RecruitingNCT06822985What this trial is testingQL1706 As Second-line Treatment in Patients with Advanced Hepatocellular CarcinomaWho this might be right forHCC - Hepatocellular Carcinoma Wan-Guang Zhang 21
Testing effectiveness (Phase 2)Study completedNCT00191984What this trial is testingThe Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Eli Lilly and Company 46
Testing effectiveness (Phase 2)Ended earlyNCT03082833What this trial is testingPhase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line ChemotherapyWho this might be right forCancer of Stomach Samsung Medical Center 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783348What this trial is testingRadiopharmaceutical Treatment of Advanced Kidney CancerWho this might be right forMetastatic Clear Cell Renal Cell Carcinoma European Organisation for Research and Treatment of Cancer - EORTC 48
Testing effectiveness (Phase 2)Study completedNCT00061308What this trial is testingSecond-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal CancerWho this might be right forPeritoneal CancerOvarian CancerNeoplasms, Ovarian+1 more GlaxoSmithKline 75
Not applicableActive Not RecruitingNCT05220917What this trial is testingComparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes StudyWho this might be right forCardiovascular EventsType2 DiabetesRenal Disease Brigham and Women's Hospital 781,430